Xtrackers MSCI World ESG UCITS ETF 1C is a equity ETF from Xtrackers tracking the MSCI World ESG index through physical replication. Domiciled in Ireland and launched in 2018, the fund manages about 5 bn € and charges a TER of 0.20% — 20 € per year on a €10,000 investment. Income is automatically reinvested in the fund (accumulating).
Xtrackers MSCI World ESG UCITS ETF 1C competes with 2 other products on the same index (MSCI World ESG): it ranks 1st by fund size and 1st by ongoing cost, with a TER of 0.20% against a group median of 0.20%. It has been listed since 2018, 8 years of track record — the oldest in its comparison group.
On a €10,000 investment the TER costs 20 € a year, and no product in the group costs less.
Replication is physical: the fund holds the underlying securities directly. The ten largest positions account for 37.7% of the portfolio.
Income is accumulated: no distribution is paid out, the share price absorbs it. In a savings plan this removes the need to reinvest dividends by hand. The fund is denominated in EUR. That is not the same as currency risk: the exposure comes from the currencies of the underlying holdings, not from the denomination or the trading currency of a given listing.
Irish domicile lets the fund apply the Ireland–US tax treaty, with 15% withholding instead of 30% on US dividends received by the fund.
| NVIDIA Corporation | 9.7% |
| Microsoft Corporation | 6.7% |
| Alphabet Inc Class A | 4.9% |
| Alphabet Inc Class C | 3.8% |
| Tesla Inc | 3.0% |
| Eli Lilly and Company | 2.5% |
| Advanced Micro Devices Inc | 2.4% |
| Intel Corporation | 1.6% |
| Johnson & Johnson | 1.6% |
| Visa Inc. Class A | 1.5% |
| Borsa Italiana | XZW0 | EUR |
| XETRA | XZW0 | EUR |
| Francoforte | XZW0 | EUR |
| London Stock Exchange | XZW0 | USD |
| London Stock Exchange | XESW | GBP |
Source: the fund's KID and the issuer's official documentation — data verified as of July 2026.
This page is informational and is not an investment recommendation. Figures may contain errors or be out of date: always check the KID and the issuer's factsheet before any decision.